Outcome of patients aged 60‐75 years with newly diagnosed secondary acute myeloid leukemia: A single‐institution experience

A recent phase 3 trial showed that outcome of older patients with secondary acute myeloid leukemia (AML) may be improved by a liposomal encapsulation of cytarabine and daunorubicin (CPX‐351). This phase 3 study represents a unique example of prospective data in this rare subgroup providing basis for...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cancer Med
Hlavní autoři: Bertoli, Sarah, Tavitian, Suzanne, Bories, Pierre, Luquet, Isabelle, Delabesse, Eric, Comont, Thibault, Sarry, Audrey, Huguet, Françoise, Bérard, Emilie, Récher, Christian
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2019
Témata:
Clinical Cancer Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6639188/
https://ncbi.nlm.nih.gov/pubmed/31173485
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.2020
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky